The stocks of NYT have been given a rating of buy by around 7 research equities that have been covering the stocks of the firm. One of the investment researchers has already prescribed the stocks with a rating of sell, while five of them have given the company a rating of buy. Currently, the company has a price objective of about $46.29 which has been calculated over a course of a single year.
The Stock Commentary of NYT
There have been several research analysts that have already provided insights into the stocks of NYT. Morgan Stanley has already increased the price target of the company from $57 to $60, along with a rating of overweight in a 5th February research report. Evercore ISI has also increased the rating of the company from in-line to outperform, along with a price target which has been increased from $45 to $48 in a 9th November research report.
The stocks of NYT traded on Friday at $50.72. The moving average price of the company over a period of 50 days has been $50.62, while the moving average price of the company over the course of 200 days is $45.95. The company also has a year low of $26.13, with a year high of around $58.73. The market cap of the firm is $8.48 billion, with a PE ratio of around 53.39.
The New York Times did release their previous results of earnings on the 4th of February. The EPS reported by NYT for the quarter was $0.40, which was slightly more than the consensus estimate of $0.39. The return on equity for the firm was 13.73%, with an 8.88% net margin.